Top Markets
Coin of the day
Cyteir Therapeutics, Inc. Cyteir Therapeutics, Inc.

Cyteir Therapeutics, Inc.

CYT
Rang in aandelen #21570
Cyteir Therapeutics, Inc. is a clinical-stage biopharmaceutical firm dedicated... Cyteir Therapeutics, Inc. is a clinical-stage biopharmaceutical firm dedicated to innovating and bringing to market cutting-edge precision oncology medicines. Its flagship compound, CYT-0851, is an novel, orally administered small molecule drug candidate, designed for once-daily dosing. This therapy is currently undergoing Phase I/II clinical evaluations, both as a standalone treatment and in combination with other drugs, targeting a broad range of solid tumors and hematologic malignancies. Furthermore, the company is advancing CYT-1853, another promising candidate in preclinical development for similar oncological indications. Cyteir Therapeutics was established in 2012 and is headquartered in Lexington, Massachusetts.
Aandeelprijs
$3.01
Laatst gesynchroniseerd: 2024-04-12
Marktkapitalisatie
$104.64M
Verandering (1 dag)
0.00%
Verandering (1 jaar)
0.00%
Land
US
Handel Cyteir Therapeutics, Inc. (CYT)

Categorie

Koersgeschiedenis voor Cyteir Therapeutics, Inc. (CYT)
Hoogste slotkoers: $3.01 op 2024-04-01

Laagste slotkoers: $18.73 op 2021-06-01
Koersgeschiedenis van Cyteir Therapeutics, Inc. van 2021 tot 2026
Jaarlijkse koersprestatie
Jaar Prestaties
2024 -2.00%
2023 125.69%
2022 -88.47%
2021 0.00%
Aandelenkoers van vergelijkbare bedrijven of concurrenten
Bedrijf Aandelenkoers Verandering 1jr% Land
$547.71 38.62%
US
$1.04K 58.06%
NL
$145.75 437.43%
US
$118.70 -15.60%
AU
$770.19 8.98%
CH